170 research outputs found

    Finitely annihilated groups

    Get PDF
    We say a group is finitely annihilated if it is the set-theoretic union of all its proper normal finite index subgroups. We investigate this new property, and observe that it is independent of several other well known group properties. For finitely generated groups, we show that in many cases it is equivalent to having non-cyclic abelianisation, and at the same time construct an explicit infinite family of counterexamples to this. We show for finitely presented groups that this property is neither Markov nor co-Markov. In the context of our work we show that the weight of a non-perfect finite group, or a non-perfect finitely generated solvable group, is the same as the weight of its abelianisation. We generalise a theorem of Brodie-Chamberlain-Kappe on finite coverings of groups, and finish with some generalisations and variations of our new definition.Comment: 13 pages. This is the version submitted for publicatio

    The importance of time-varying forcing for QBO modulation of the atmospheric 11 year solar cycle signal

    Get PDF
    We present results from three multidecadal sensitivity experiments with time-varying solar cycle and quasi-biennial oscillation (QBO) forcings using National Center for Atmospheric Research's Whole Atmosphere Community Climate Model (WACCM3.1). The model experiments are unique compared to earlier studies as they use time-varying forcings for the solar cycle only and the QBO, both individually and combined. The results show that the annual mean solar response in the tropical upper stratosphere is independent of the presence of the QBO. The response in the middle to lower stratosphere differs depending on the presence of the QBO and the solar cycle but is statistically indistinguishable in the three experiments. The seasonal evolution of the solar and the combined solar-QBO signals reveals a reasonable agreement with observations only for the experiment in which both the solar cycle and the QBO forcing are present, suggesting that both forcings are important to generate the observed response. More stratospheric warmings occur during solar maximum and QBO west conditions. This appears to be the result of a QBO modulation of the background zonal mean wind climatology, which modifies the solar signal. Depending on the background wind, the small initial early winter solar signal in the subtropical upper stratosphere/lower mesosphere is enhanced during QBO east and diminished during QBO west conditions. This consequently influences the transfer of the solar-QBO signal during winter and results in the observed differences during late winte

    Combination antiretroviral therapy and the risk of myocardial infarction

    Get PDF

    Antenatal glucocorticoid treatment induces adaptations in adult midbrain dopamine neurons, which underpin sexually dimorphic behavioral resilience

    Get PDF
    We demonstrated previously that antenatal glucocorticoid treatment (AGT, gestational days 16-19) altered the size and organization of the adult rat midbrain dopaminergic (DA) populations. Here we investigated the consequences of these AGT-induced cytoarchitectural disturbances on indices of DA function in adult rats. We show that in adulthood, enrichment of striatal DA fiber density paralleled AGT-induced increases in the numbers of midbrain DA neurons, which retained normal basal electrophysiological properties. This was co-incident with changes in (i) striatal D2-type receptor levels (increased, both sexes); (ii) D1-type receptor levels (males decreased; females increased); (iii) DA transporter levels (males increased; females decreased) in striatal regions; and (iv) amphetamine-induced mesolimbic DA release (males increased; females decreased). However, despite these profound, sexually dimorphic changes in markers of DA neurotransmission, in-utero glucocorticoid overexposure had a modest or no effect on a range of conditioned and unconditioned appetitive behaviors known to depend on mesolimbic DA activity. These findings provide empirical evidence for enduring AGT-induced adaptive mechanisms within the midbrain DA circuitry, which preserve some, but not all, functions, thereby casting further light on the vulnerability of these systems to environmental perturbations. Furthermore, they demonstrate these effects are achieved by different, often opponent, adaptive mechanisms in males and females, with translational implications for sex biases commonly found in midbrain DA-associated disorders

    Clozapine's functional mesolimbic selectivity is not duplicated by the addition of anticholinergic action to haloperidol: a brain stimulation study in the rat

    Full text link
    This study examined whether the anticholinergic potency of the clinically superior antipsychotic drug clozapine contributes to clozapine's anatomically-selective functional inhibition of the mesolimbic dopamine (DA) system, using an electrical brain-stimulation reward (BSR) paradigm in rats that has been previously shown to be highly sensitive to clozapine's mesolimbic functional selectivity. Rats were chronically administered saline, clozapine, haloperidol, or haloperidol plus the anticholinergic compound trihexyphenidyl, and threshold sensitivity of the mesolimbic and nigrostriatal DA systems was assessed using the BSR paradigm, to infer degree of functional DA blockade produced by the chronic drug regimens. Chronic saline produced no change in either DA system. Congruent with previous findings, chronic clozapine powerfully inhibited the mesolimbic DA system but spared the nigrostriatal DA system. Also congruent with previous findings, chronic haloperidol powerfully inhibited both DA systems. Compared to chronic haloperidol alone, chronic haloperidol plus chronic trihexyphenidyl exerted diminished anti-DA action in both the mesolimbic and nigrostriatal DA systems. These results suggest that clozapine's anticholinergic potency is not an adequate explanation for its functional mesolimbic selectivity.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/46341/1/213_2005_Article_BF02246960.pd

    Role of Kv1 Potassium Channels in Regulating Dopamine Release and Presynaptic D2 Receptor Function

    Get PDF
    Dopamine (DA) release in the CNS is critical for motor control and motivated behaviors. Dysfunction of its regulation is thought to be implicated in drug abuse and in diseases such as schizophrenia and Parkinson's. Although various potassium channels located in the somatodendritic compartment of DA neurons such as G-protein-gated inward rectifying potassium channels (GIRK) have been shown to regulate cell firing and DA release, little is presently known about the role of potassium channels localized in the axon terminals of these neurons. Here we used fast-scan cyclic voltammetry to study electrically-evoked DA release in rat dorsal striatal brain slices. We find that although G-protein-gated inward rectifying (GIRK) and ATP-gated (KATP) potassium channels play only a minor role, voltage-gated potassium channels of the Kv1 family play a major role in regulating DA release. The use of Kv subtype-selective blockers confirmed a role for Kv1.2, 1.3 and 1.6, but not Kv1.1, 3.1, 3.2, 3.4 and 4.2. Interestingly, Kv1 blockers also reduced the ability of quinpirole, a D2 receptor agonist, to inhibit evoked DA overflow, thus suggesting that Kv1 channels also regulate presynaptic D2 receptor function. Our work identifies Kv1 potassium channels as key regulators of DA release in the striatum

    Glyconanomaterials for biosensing applications

    Full text link

    Toxocariasis: a silent threat with a progressive public health impact

    Get PDF
    Background: Toxocariasis is a neglected parasitic zoonosis that afflicts millions of the pediatric and adolescent populations worldwide, especially in impoverished communities. This disease is caused by infection with the larvae of Toxocara canis and T. cati, the most ubiquitous intestinal nematode parasite in dogs and cats, respectively. In this article, recent advances in the epidemiology, clinical presentation, diagnosis and pharmacotherapies that have been used in the treatment of toxocariasis are reviewed. Main text: Over the past two decades, we have come far in our understanding of the biology and epidemiology of toxocariasis. However, lack of laboratory infrastructure in some countries, lack of uniform case definitions and limited surveillance infrastructure are some of the challenges that hindered the estimation of global disease burden. Toxocariasis encompasses four clinical forms: visceral, ocular, covert and neural. Incorrect or misdiagnosis of any of these disabling conditions can result in severe health consequences and considerable medical care spending. Fortunately, multiple diagnostic modalities are available, which if effectively used together with the administration of appropriate pharmacologic therapies, can minimize any unnecessary patient morbidity. Conclusions: Although progress has been made in the management of toxocariasis patients, there remains much work to be done. Implementation of new technologies and better understanding of the pathogenesis of toxocariasis can identify new diagnostic biomarkers, which may help in increasing diagnostic accuracy. Also, further clinical research breakthroughs are needed to develop better ways to effectively control and prevent this serious disease
    • …
    corecore